EQT has led a $102.5 million Series A funding round in PanTera, a Belgian company specializing in the production of radioisotopes. The investment aims to boost the company's production capabilities and expand its market reach.
Who to call at PanTera, and when
A new round usually means PanTera is about to hire and buy. The teams that reach out first get the meeting.
An alert the day PanTera raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at PanTera, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PanTera. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
PanTera
Location
Mol, Antwerp, Belgium
About
PanTera aims to secure the large-scale production of actinium-225 (225Ac), one of the most promising alpha-emitting radioisotopes to fight cancers by Targeted RadioTherapy (TRT). By working towards this large-scale production, PanTera’s ultimate goal is to improve the accessibility of future innovative cancer therapy based on 225Ac and theranostics in general.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PanTera raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MolManufacturingBiotechnologyHealth CareMedicalMedical Device